Ryssel, H.; Ahlborn, L.B.; Dejanovic, D.; Keller, S.H.; Pøhl, M.; Østrup, O.; Loft, A.; Fischer, B.M.; Langer, S.W.; Kjaer, A.;
et al. Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC. Diagnostics 2025, 15, 247.
https://doi.org/10.3390/diagnostics15030247
AMA Style
Ryssel H, Ahlborn LB, Dejanovic D, Keller SH, Pøhl M, Østrup O, Loft A, Fischer BM, Langer SW, Kjaer A,
et al. Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC. Diagnostics. 2025; 15(3):247.
https://doi.org/10.3390/diagnostics15030247
Chicago/Turabian Style
Ryssel, Heidi, Lise Barlebo Ahlborn, Danijela Dejanovic, Sune Hoegild Keller, Mette Pøhl, Olga Østrup, Annika Loft, Barbara Malene Fischer, Seppo Wang Langer, Andreas Kjaer,
and et al. 2025. "Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC" Diagnostics 15, no. 3: 247.
https://doi.org/10.3390/diagnostics15030247
APA Style
Ryssel, H., Ahlborn, L. B., Dejanovic, D., Keller, S. H., Pøhl, M., Østrup, O., Loft, A., Fischer, B. M., Langer, S. W., Kjaer, A., & Christensen, T. N.
(2025). Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC. Diagnostics, 15(3), 247.
https://doi.org/10.3390/diagnostics15030247
